KRO

Koppers Holdings Inc. KOP logged earnings (as reported) of 35 cents per share for the first quarter of 2026. This compares favorably with a loss of 68 cents a year ago. Barring one-time items, adjusted earnings were 57 cents per share for the quarter, which fell from 71 cents a year ago and beat the Zacks Consensus Estimate of 44 cents. Koppers recorded revenues of $455.3 million for the quarter, down around 0.3% year over year. The top line beat the Zacks Consensus Estimate of $410.5 million by roughly 10.9%. Adjusted EBITDA was $49.3 million, down 11.2% year over year, with margin contracting to 10.8% from 12.2%. Sales were mixed across segments in the quarter, with strength in Performance Chemicals (PC) offset by declines in Railroad and Utility Products and Services (RUPS) and Carbon Materials and Chemicals (CMC). Koppers Holdings Inc. price-consensus-eps-surprise-chart | Koppers Holdings Inc. Quote RUPS: Sales from the segment fell around 6.4% year over year to $220 million in the reported quarter. Adjusted EBITDA declined 11.4% to $22.6 million, and margin contracted to 10.3% from 10.9%. The decline was due to customer mix in Class I crossties, lower maintenance-of-way activity, including roughly $9.6 million tied to the sale of the railroad services business in the third quarter of 2025, and price decreases across multiple markets, particularly crossties. These headwinds were partly offset by higher domestic utility pole volumes, including the acquisition of a western U.S. pole procurement business, higher commercial crosstie volumes and a $1.4 million favorable foreign currency impact, mainly from the Australian utility pole business. PC: The segment recorded sales of $142.1 million in the quarter, up around 17.5% year over year. Adjusted EBITDA increased 28.4% to $25.8 million, with margin expanding to 18.2% from 16.6%. The gains were driven by a 15% increase in volumes and higher sales prices, mainly in the Americas. International foreign currency changes provided a $2.7 million favorable impact, while $2.4 million of higher raw material and operating costs partly offset the improvement, including higher scrap copper costs net of benefits from the company's copper-hedging program. CMC: Sales from the division fell around 7.4% year over year to $93.2 million. Adjusted EBITDA plunged 90.9% to $0.9 million, with margin down to 1% from 9.8%. The declin...

Avient Corporation AVNT reported adjusted earnings of 83 cents per share for the first quarter of 2026, up 9.2% from 76 cents a year ago. The bottom line beat the Zacks Consensus Estimate of 81 cents by 2.5%. Net sales were $847.4 million, up 2.5% year over year and slightly ahead of the Zacks Consensus Estimate of $845.8 million. The top line improved despite a challenging backdrop, with sales growth supported by currency translation. AVNT highlighted that first-quarter sales growth included a 5% favorable foreign exchange impact. Profitability improved alongside revenues. Adjusted EBITDA rose to $149.9 million from $144.7 million a year ago, taking adjusted EBITDA as a percent of sales to 17.7% from 17.5%. The results benefited from productivity improvement and cost-control actions. Avient Corporation price-consensus-eps-surprise-chart | Avient Corporation Quote Color, Additives and Inks sales were $528.1 million in the quarter, up 1.6% from $519.7 million a year ago. Segment EBITDA increased to $103.8 million from $100.3 million, implying an EBITDA margin of about 19.7% versus roughly 19.3% in the prior-year quarter. Specialty Engineered Materials generated sales of $320.2 million, up 3.8% from $308.4 million in the year-ago quarter. Segment EBITDA rose to $70 million from $68.6 million, translating to an EBITDA margin of about 21.9% compared with approximately 22.2% a year ago. Avient ended the quarter with cash and cash equivalents of $427.6 million, down from $510.5 million in the prior quarter. Long-term debt was essentially steady at $1,924 million versus $1,922.6 million at year-end 2025. Net cash used in operating activities was $34.5 million compared with $51.1 million used in the prior-year quarter, while capital expenditures were $19 million versus $12.5 million a year ago. AVNT guided to second-quarter adjusted earnings of 89 cents per share, which management said would represent 11% growth over the prior-year quarter. The company also emphasized that its first-half expectations are now slightly better than expected versus the start of the year. For full-year 2026, Avient maintained its adjusted EPS guidance range of $2.93 to $3.17 and reiterated its adjusted EBITDA outlook of $555 million to $585 million. Management noted that the outlook for the second half of the year is less certain, supporting its decision to keep the full-year targets unc...

DALLAS, TEXAS, May 13, 2026 (GLOBE NEWSWIRE) -- Kronos Worldwide, Inc. (NYSE: KRO) announced that its board of directors has declared a regular quarterly dividend of five cents ($0.05) per share on its common stock, payable on June 18, 2026 to stockholders of record at the close of business on June 4, 2026. Kronos Worldwide also announced that at its 2026 annual stockholder meeting held today its stockholders had: elected each of Brian W. Christian, Loretta J. Feehan, John E. Harper, Kevin B. Kramer, Meredith W. Mendes, Cecil H. Moore, Jr., Michael S. Simmons, and R. Gerald Turner as a director for a one-year term; and adopted a resolution that approved, on a nonbinding advisory basis, the compensation of its named executive officers as disclosed in the proxy statement for the 2026 annual stockholder meeting. Kronos Worldwide, Inc. is a major international producer of titanium dioxide products. * * * * * Investor Relations Contact Bryan A. Hanley Senior Vice President and Treasurer Tel. 972-233-1700

Kronos Worldwide, Inc. KRO reported a first-quarter 2026 net loss of 4 cents per share, narrower than the Zacks Consensus Estimate of a loss of 33 cents. Earnings delivered a positive surprise of 87.9%. Net sales were $509.8 million, up 4.1% year over year, but missed the consensus mark of $523.8 million by 2.7%. The quarter reflected improving cost performance, while weaker year-over-year pricing and lower production weighed on profitability. Kronos Worldwide Inc price-consensus-eps-surprise-chart | Kronos Worldwide Inc Quote TiO2 sales volumes rose 4.4% year over year to 142 thousand metric tons in the quarter, supported by higher volumes in North American, Latin American and export markets. Production volumes, however, declined 10.5% to 128 thousand metric tons, reflecting lower operating rates. On pricing, the company started 2026 with average TiO2 selling prices below the beginning of 2025. Management noted that average TiO2 selling prices increased 2% during the quarter as it works to recover pricing lost during 2025, but pricing remained a year-over-year headwind to both sales and profits. Kronos reported TiO2 segment profit of $15.1 million in the first quarter, down from $41.6 million a year ago. Management attributed the decline primarily to lower average TiO2 selling prices, lower production volumes and an unfavorable currency impact, partially offset by higher sales volumes and lower production costs. Kronos ended the quarter with cash and cash equivalents of $25.7 million as of March 31, 2026, down from $33.2 million at the end of 2025. Long-term debt stood at $602.7 million as of March 31, 2026, up from $557.4 million as of Dec. 31, 2025. Management emphasized continued execution on pricing and cost initiatives as the key operational priorities following the restructuring actions taken late in 2025. Additional increases will be needed as selling prices remain below 2025 levels. Kronos expects gross margin to improve as higher-cost inventory produced in late 2025 works through the system and it realizes the benefit of lower-cost production in 2026, though it is beginning to see higher shipping and production costs tied to Middle East-related supply disruptions and higher energy and raw material costs, particularly in Europe. Customers are still cautious on inventories, but longer lead times and a higher backlog entering 2026 have improved near-t...

DALLAS (AP) — DALLAS (AP) — Kronos Worldwide Inc. (KRO) on Wednesday reported a loss of $4.8 million in its first quarter. On a per-share basis, the Dallas-based company said it had a loss of 4 cents. The maker of titanium dioxide pigments posted revenue of $509.8 million in the period. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KRO at https://www.zacks.com/ap/KRO

DALLAS, TEXAS, May 06, 2026 (GLOBE NEWSWIRE) -- Kronos Worldwide, Inc. (NYSE:KRO) today reported a net loss of $4.8 million, or $.04 per share, in the first quarter of 2026 compared to net income of $18.1 million, or $.16 per share, in the first quarter of 2025. Net income decreased in the first quarter of 2026 compared to the prior year period primarily due to lower income from operations as a result of lower average TiO2 selling prices and lower production volumes, partially offset by higher sales volumes and lower production costs driven primarily by cost reduction initiatives implemented in the fourth quarter of 2025 to structurally realign our operations, as well as lower raw material and energy costs. Comparability of our results was also impacted by the effects of changes in currency exchange rates. Net sales of $509.8 million in the first quarter of 2026 were $20.0 million, or 4%, higher than in the first quarter of 2025. Net sales increased in the first quarter of 2026 compared to the first quarter of 2025 primarily due to the effects of higher sales volumes in our North American, Latin American and export markets and the favorable impact of changes in currency exchange rates (primarily the euro), which we estimate increased our net sales by approximately $30 million. These increases were partially offset by lower sales volumes in our European market and lower average TiO2 selling prices. We started 2026 with average TiO2 selling prices lower than at the beginning of 2025; however, our average TiO2 selling prices increased 2% during the first quarter of 2026 as we work to recover pricing lost during 2025. The table at the end of this press release shows how each of these items impacted net sales. Our TiO2 segment profit (see description of non-GAAP information below) was $15.1 million in the first quarter of 2026 compared to $41.6 million in the first quarter of 2025. Segment profit decreased in the first quarter of 2026 compared to the first quarter of 2025 primarily due to the effects of lower average TiO2 selling prices, lower production volumes, and the unfavorable impact of changes in currency exchange rates, partially offset by higher sales volumes and lower production costs. Lower production costs benefited in part from cost reduction initiatives implemented in the fourth quarter of 2025, including workforce reductions and other measures, whi...

Cabot (CBT) came out with quarterly earnings of $1.61 per share, beating the Zacks Consensus Estimate of $1.47 per share. This compares to earnings of $1.9 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +9.61%. A quarter ago, it was expected that this chemical company would post earnings of $1.4 per share when it actually produced earnings of $1.53, delivering a surprise of +9.29%. Over the last four quarters, the company has surpassed consensus EPS estimates three times. Cabot, which belongs to the Zacks Chemical - Diversified industry, posted revenues of $904 million for the quarter ended March 2026, missing the Zacks Consensus Estimate by 1.33%. This compares to year-ago revenues of $936 million. The company has not been able to beat consensus revenue estimates over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Cabot shares have added about 14.4% since the beginning of the year versus the S&P 500's gain of 5.2%. While Cabot has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Cabot was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be int...

Eastman Chemical (EMN) came out with quarterly earnings of $1.09 per share, beating the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $1.91 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +1.68%. A quarter ago, it was expected that this specialty chemicals maker would post earnings of $0.76 per share when it actually produced earnings of $0.75, delivering a surprise of -1.32%. Over the last four quarters, the company has surpassed consensus EPS estimates just once. Eastman Chemical, which belongs to the Zacks Chemical - Diversified industry, posted revenues of $2.18 billion for the quarter ended March 2026, missing the Zacks Consensus Estimate by 1.47%. This compares to year-ago revenues of $2.29 billion. The company has not been able to beat consensus revenue estimates over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Eastman Chemical shares have added about 10.3% since the beginning of the year versus the S&P 500's gain of 4.2%. While Eastman Chemical has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Eastman Chemical was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list...

Methanex (MEOH) came out with quarterly earnings of $0.3 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $1.3 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -36.17%. A quarter ago, it was expected that this methanol supplier would post earnings of $0.81 per share when it actually produced a loss of $0.14, delivering a surprise of -117.28%. Over the last four quarters, the company has surpassed consensus EPS estimates just once. Methanex, which belongs to the Zacks Chemical - Diversified industry, posted revenues of $974 million for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 1.04%. This compares to year-ago revenues of $896 million. The company has topped consensus revenue estimates just once over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Methanex shares have added about 52.1% since the beginning of the year versus the S&P 500's gain of 4.3%. While Methanex has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Methanex was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #1 (Strong Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here....

Stepan Co. (SCL) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.84 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +114.29%. A quarter ago, it was expected that this specialty chemicals company would post earnings of $0.35 per share when it actually produced a loss of $0.02, delivering a surprise of -105.71%. Over the last four quarters, the company has surpassed consensus EPS estimates two times. Stepan Co., which belongs to the Zacks Chemical - Diversified industry, posted revenues of $604.51 million for the quarter ended March 2026, missing the Zacks Consensus Estimate by 4.09%. This compares to year-ago revenues of $593.26 million. The company has topped consensus revenue estimates just once over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Stepan Co. shares have added about 11.2% since the beginning of the year versus the S&P 500's gain of 4.8%. While Stepan Co. has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Stepan Co. was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #5 (Strong Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 R...

DALLAS, TEXAS, April 14, 2026 (GLOBE NEWSWIRE) -- Kronos Worldwide, Inc. (NYSE: KRO) announced today that, subject to the completion of quarter-end closing procedures, it expects to report first quarter 2026 earnings in a press release after market close on Wednesday, May 6, 2026. Kronos Worldwide, Inc. is a major international producer of titanium dioxide products. * * * * * Investor Relations Contact Bryan A. Hanley Senior Vice President and Treasurer Tel. 972-233-1700

A month has gone by since the last earnings report for Kronos Worldwide (KRO). Shares have added about 22.7% in that time frame, outperforming the S&P 500. But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Kronos Worldwide due for a pullback? Well, first let's take a quick look at the most recent earnings report in order to get a better handle on the recent catalysts for Kronos Worldwide Inc before we dive into how investors and analysts have reacted as of late. Kronos reported a fourth-quarter 2025 net loss of $82.8 million or 72 cents per share. This compares unfavorably to a loss of $13.2 million, or 12 cents per share, in the year-ago quarter. It was wider than the Zacks Consensus Estimate of a loss of 26 cents. Net sales decreased around 1.1% year over year to $418.3 million. The decline was mainly due to lower average TiO2 selling prices, partly offset by higher sales volumes in the European market. The top line beat the Zacks Consensus Estimate of $372.3 million. TiO2 production volumes (thousand metric tons) were down 36.8% year over year to 86 in the fourth quarter. TiO2 sales volumes (thousand metric tons) increased around 7.3% to 118 in the quarter. TiO2 segment loss was $59.4 million in the reported quarter compared with a segment profit of $33.1 million a year ago. The downside was mainly due to reduced income from operations as a result of unfavorable fixed cost absorption stemming from reduced operating rates at certain of Kronos’ manufacturing facilities and increased costs related to workforce reduction initiatives. Kronos ended the year with cash and cash equivalents of $33.2 million, down around 68.9% from the prior year. Long-term debt amounted to $557.4 million, up around 30% year over year. The company expects demand to improve in 2026, supported by low customer inventories and seasonal restocking, particularly in North America. However, the pace and sustainability are subject to macroeconomic factors, including interest rates, inflation and consumer confidence. Demand in Europe continues to remain below historical levels. However, the company anticipates European volumes to increase from 2025 levels, considering industry capacity reductions, including the Venator bankruptcy and the associated plant closures. It remains focused on permanently realigning its operati...